Neocis Inc

08/23/2022 | Press release | Archived content

Neocis’ Imageless YomiPlan Go Workflow Launches Commercially

YomiPlan Go, the latest software mode in the expanding YomiPlan suite, received 510(k) clearance from the U.S. Food and Drug Administration in June following a successful clinical study - Neocis' 13th FDA clearance to date.

Neocis Inc published this content on August 23, 2022, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 21, 2026 at 09:21 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]